Back to Journals » Drug Design, Development and Therapy » Volume 11

Sodium-glucose cotransporter 2 inhibitors combined with dipeptidyl peptidase-4 inhibitors in the management of type 2 diabetes: a review of current clinical evidence and rationale
Total article views | Abstract views | HTML views | PDF downloads | Totals | |
---|---|---|---|---|---|
12,583 | Dovepress* | 7,826 | 3,024+ | 1,540 | 10,850 |
PubMed Central* | 0 | 1,733 | 360 | 1,733 | |
Totals | 7,826 | 4,757 | 1,900 | 12,583 | |
*Since 21 March 2017 +Since July 2016 |
View citations on PubMed Central and Google Scholar